- Home
- KITT vs HOTH Comparison
KITT vs HOTH Comparison
Compare KITT & HOTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KITT
- HOTH
- Stock Information
- Founded
- KITT 2014
- HOTH 2017
- Country
- KITT United States
- HOTH United States
- Employees
- KITT N/A
- HOTH N/A
- Industry
- KITT Industrial Machinery/Components
- HOTH Biotechnology: Pharmaceutical Preparations
- Sector
- KITT Industrials
- HOTH Health Care
- Exchange
- KITT Nasdaq
- HOTH Nasdaq
- Market Cap
- KITT 16.4M
- HOTH 15.6M
- IPO Year
- KITT N/A
- HOTH 2019
- Fundamental
- Price
- KITT $3.28
- HOTH $1.53
- Analyst Decision
- KITT
- HOTH Strong Buy
- Analyst Count
- KITT 0
- HOTH 3
- Target Price
- KITT N/A
- HOTH $4.00
- AVG Volume (30 Days)
- KITT 751.1K
- HOTH 1.3M
- Earning Date
- KITT 11-11-2025
- HOTH 11-11-2025
- Dividend Yield
- KITT N/A
- HOTH N/A
- EPS Growth
- KITT N/A
- HOTH N/A
- EPS
- KITT N/A
- HOTH N/A
- Revenue
- KITT $3,082,232.00
- HOTH N/A
- Revenue This Year
- KITT $2,936.06
- HOTH N/A
- Revenue Next Year
- KITT N/A
- HOTH N/A
- P/E Ratio
- KITT N/A
- HOTH N/A
- Revenue Growth
- KITT N/A
- HOTH N/A
- 52 Week Low
- KITT $2.85
- HOTH $0.65
- 52 Week High
- KITT $54.36
- HOTH $3.80
- Technical
- Relative Strength Index (RSI)
- KITT 54.66
- HOTH 45.55
- Support Level
- KITT $2.85
- HOTH $1.49
- Resistance Level
- KITT $3.65
- HOTH $1.62
- Average True Range (ATR)
- KITT 0.34
- HOTH 0.14
- MACD
- KITT -0.08
- HOTH -0.05
- Stochastic Oscillator
- KITT 26.99
- HOTH 10.69
About KITT Nauticus Robotics Inc.
Nauticus Robotics Inc develops fully electric autonomous robotic solutions for subsea applications. The company's business model includes using robotic systems for service, selling vehicles and components, and licensing related software to both the commercial and defense business sectors. The company's addressable markets include upstream, midstream, and downstream oil and gas, defense, offshore renewables, seafloor telecommunications, aquaculture, port security, oceanographic research, and subsea mining.
About HOTH Hoth Therapeutics Inc.
Hoth Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing new-generation therapies for unmet medical needs. It is focused on developing a topical formulation for treating side effects from drugs used for the treatment of cancer (HT-001); a treatment for mast-cell derived cancers and anaphylaxis (HT-KIT); and a treatment and/or prevention for Alzheimer's or other neuroinflammatory diseases (HT-ALZ). The company also has assets being developed for atopic dermatitis (also known as eczema) (BioLexa); a treatment for asthma and allergies using inhalational administration (HT-004); and an obesity treatment, and obesity-related diseases and conditions (HT-VA).